Quantcast
Last updated on April 17, 2014 at 15:58 EDT

Latest Suicidal ideation Stories

2005-12-23 09:24:15

By Karla Gale NEW YORK (Reuters Health) - Men with severe depression are more likely to commit suicide if they abuse alcohol and have "cluster B" personality disorder, which relates to impulsive and/or aggressive behavior, new study findings suggest. "Why some patients with major depressive disorder die by suicide while others with seemingly the same disorder do not, is a question of enormous clinical relevance," Dr. Gustavo Turecki and colleagues write in the American Journal of...

2005-10-18 21:47:57

As Australia tries to arrest its national suicide rate, new University of Western Sydney research reveals that many suicide attempts are unplanned, with a good portion of suicide survivors reporting they felt the urge to harm themselves less than ten minutes before acting on it. Dr Marianne Wyder, a PhD graduate from the UWS Social Justice Social Change Research Centre, studied 90 people aged between 17 to 65 years, who had attempted suicide and had been taken to a hospital emergency...

2005-10-10 14:48:21

Researchers have found provocative evidence that the brain dysfunction that underlies epilepsy may also determine whether people are at risk for suicide. The study, published online October 10, 2005 in the Annals of Neurology (www.interscience.wiley.com/journal/ana), also suggests that depression and suicide may have different brain mechanisms. "For reasons that are not understood, depression both increases the risk for developing epilepsy and is also common among people with epilepsy who...

2005-09-29 14:30:42

By Ransdell Pierson NEW YORK (Reuters) - Eli Lilly and Co. on Thursday said it will add strong warnings to its label for Strattera, used to treat attention-deficit/hyperactivity disorder, including the risk of suicidal thoughts among children and adolescents. Strattera will now carry a "black box" warning, the strongest required by U.S. regulators. Such warnings typically hurt sales of products by raising concern among doctors and patients about the safety of a drug. The...

2005-09-29 11:49:02

CHICAGO (Reuters) - Eli Lilly and Co. on Thursday said it will add strong warnings to its label for Strattera, used to treat attention-deficit/hyperactivity disorder, including the risk of suicidal thoughts among children and adolescents. Strattera will now carry a "black box" warning, the strongest required by U.S. regulators. Such warnings typically hurt sales of products by raising concern among doctors and patients about the safety of a drug. The Indianapolis drugmaker said a...

2005-09-29 11:27:56

CHICAGO (Reuters) - Eli Lilly and Co. on Thursday said it will add strong warnings to its label for Strattera, used to treat attention-deficit/hyperactivity disorder, including the risk of suicidal thoughts among children and adolescents. Strattera will now carry a "black box" warning, the strongest required by U.S. regulators. Lilly said there were no suicides among children, adolescents or adults taking the medication during Strattera clinical trials, but there was one suicide...

2005-09-29 07:43:45

Please correct spelling of drug name in headline and throughout story to "Strattera" from "Straterra." A corrected version follows. CHICAGO (Reuters) - Eli Lilly and Co. on Thursday said it will add strong warnings to its label for Strattera, used to treat attention-deficit/hyperactivity disorder, including the risk of suicidal thoughts among children and adolescents. Strattera will carry a "black box" warning, the strongest required by U.S. regulators. Lilly said there were no...

2005-09-29 07:34:33

CHICAGO (Reuters) - Eli Lilly and Co. on Thursday said will add strong warnings to its label for Straterra, used to treat attention-deficit/hyperactivity disorder, including the risk of suicidal thoughts among children and adolescents. Straterra will carry a "black box" warning, the strongest required by U.S. regulators. Lilly said there were no suicides among children, adolescents or adults taking the medication during Straterra clinical trials, but there was one suicide attempt in...

2005-09-29 07:53:54

CHICAGO (Reuters) - Eli Lilly and Co. on Thursday said it will add strong warnings to its label for Strattera, used to treat attention-deficit/hyperactivity disorder, including the risk of suicidal thoughts among children and adolescents. Strattera will now carry a "black box" warning, the strongest required by U.S. regulators. Lilly said there were no suicides among children, adolescents or adults taking the medication during Strattera clinical trials, but there was one suicide...

2005-09-09 14:17:17

NEW YORK (Reuters Health) - Adolescent children of mothers who have attempted suicide are themselves at increased risk of doing the same thing, German research report. Dr. Roselind Lieb, from the Max Planck Institute of Psychiatry in Munich, and her associates followed a representative community sample of 933 teenagers, who were between 14 and 17 years old in 1995, along with their mothers. As reported in the American Journal of Psychiatry, the subjects were assessed at the beginning...